The global ertapenem market is expected to grow at a significant CAGR during the forecast period (2021-2027). Ertapenem is an antibiotic that is used to treat infections in the skin, lungs, stomach, pelvic, and urinary tract caused by bacteria. Ertapenem is also used for people who are having certain types of surgery which involves a risk of becoming infected. The key companies operating in the industry are highly inclined towards the adoption of different growth strategies including capacity expansion, partnerships and collaborations, mergers and acquisitions, geographical expansion, and new product launches, to remain competitive in the marketplace. For instance, in May 2021, Dr. Reddy’s Laboratories Ltd. along with its subsidiaries together referred to as Dr. Reddy’s declared the launch of Ertapenem for Injection, 1 g/vial, a therapeutic equivalent generic version of INVANZ (ertapenem for injection) for injection, 1 g/vial approved by the US Food and Drug Administration (USFDA). Additionally, the company has extended its strategic collaboration with Gland Pharma who have led the execution of this launch. Dr. Reddy’s Ertapenem for Injection, 1 g/vial, is available in packs of 10 vials per carton.
To Request a Sample of our Report on Ertapenem Market: https://www.omrglobal.com/request-sample/ertapenem-market
Moreover, in July 2018, Endo International PLC announced that Par Pharmaceutical (Par), one of its operational companies, has started selling an authorized generic version of Merck’s INVANZ (ertapenem for injection). Endo Ventures Ltd., a subsidiary of Endo, recently signed an exclusive supply and distribution deal with Merck & Co., Inc. allowing Par to launch and market an authorized generic version of the medicine.
Market Coverage
- The market number available for – 2020-2027
- Base year- 2020
- Forecast period- 2021-2027
Segment Covered-
- By Type
- By Application
Regions covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape: Merck & Co., Inc., Fresenius SE & Co. KGaA (Fresenius Kabi), and Cipla Ltd., among others.
(Get 15% Discount on Buying this Report)
A full Report of Ertapenem Market is Available @ https://www.omrglobal.com/industry-reports/ertapenem-market
Global Ertapenem Market Report by Segment
By Type
- Purity: Above 98%
- Purity: Above 99%
By Application
- Injection
- Tablet
Global Ertapenem Market Report by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
- Latin America
- Middle East & Africa
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
